(Q36999938)

English

Ischemic preconditioning: from molecular mechanisms to therapeutic opportunities

scientific article published on February 2008

In more languages

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

17 August 2017

1 reference

Europe PubMed Central

title

Ischemic preconditioning: from molecular mechanisms to therapeutic opportunities (English)

1 reference

stated in

Europe PubMed Central

17 August 2017

Hajime Otani

1

1 reference

stated in

Europe PubMed Central

PubMed ID

17999631

retrieved

17 August 2017

language of work or name

1 reference

1 February 2008

1 reference

stated in

Europe PubMed Central

17 August 2017

Antioxidants & Redox Signaling

1 reference

stated in

Europe PubMed Central

17 August 2017

10

1 reference

stated in

Europe PubMed Central

17 August 2017

2

1 reference

stated in

Europe PubMed Central

17 August 2017

207-247

1 reference

stated in

Europe PubMed Central

17 August 2017

Pharmacological preconditioning with resveratrol: role of nitric oxide

1 reference

3 January 2024

https://opencitations.net/index/api/v1/citations/10.1152/AJPHEART.01012.2001

Ischemic preconditioning triggers nuclear translocation of thioredoxin and its interaction with Ref-1 potentiating a survival signal through the PI-3-kinase-Akt pathway

1 reference

3 January 2024

https://opencitations.net/index/api/v1/citations/10.1089/ARS.2006.8.2101

Identifiers

DOI

10.1089/ARS.2007.1679

1 reference

stated in

Europe PubMed Central

17 August 2017

1 reference

Europe PubMed Central

PubMed ID

17999631

retrieved

17 August 2017

(Q36999938)

Ischemic preconditioning: from molecular mechanisms to therapeutic opportunities

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)